Life Sciences
Haydale Graphene Industries plc
Year
2023
Transaction type
Equity Capital Markets & Corporate Broking
Sector
Life Sciences
Cavendish is delighted to have acted as nominated adviser and broker in connection with Haydale Graphene Industries plc recent £5.1 m fundraising.
Haydale is a leading global technology solutions company that specialises in the design, development, and commercialisation of advanced materials using graphene and other nanomaterials.
Julian Blunt, Corporate Finance Director at Cavendish, commented:
“We are pleased to have raised the funds to allow Haydale to continue to develop the ongoing commercialisation of its proprietary HDPlas® plasma functionalisation process”.
Deals in the sector
Related News
Leveraging the UK’s Healthcare & Life Science Sector
August 19, 2024
AI Strategy and Guidance
July 24, 2024
Update to the QCA Code
July 2, 2024
Shareholder Activism and Engagement
July 2, 2024
Sector Update – Technology
June 29, 2024
Meet the New Chair of the AIC
June 27, 2024